What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.
Maya RonseAlmudena Marí SáezCharlotte GryseelsMelanie Bannister-TyrrellAlexandre DelamouAlain GuillardMustapha BrikiFrédéric BigeyNyankoye HabaJohan van GriensvenKoen Peeters GrietensPublished in: PLoS neglected tropical diseases (2018)
Ebola-Tx was the first trial to solicit and evaluate blood-product donation as an experimental treatment on a large scale in Sub-Saharan Africa. An effective donation system requires directly engaging with emergent social barriers and providing an effective ethical response, including improved and transparent communication, effective follow-up after donation, assuring confidentiality and determining ethical incentives.